Jinjun Shi

Dr. Jinjun Shi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
XSXiangyu Su
Xiangyu Su
XDXu Ding
Xu Ding
CDChenxi Ding
Chenxi Ding
GWGuoqing Wang
Guoqing Wang
CFChenchun Fu
Chenchun Fu
WHWei He
Wei He

12 June 2025 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
LALi An
Li An
JSJinjun Shi
Jinjun Shi
YPYe Pan
Ye Pan
YDYu Ding
Yu Ding
WGWEI GAO
WEI GAO
YWYao Wang
Yao Wang

1 December 2021 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
CFChenchun Fu
Chenchun Fu
JSJinjun Shi
Jinjun Shi
XSXiangyu Su
Xiangyu Su
SFShicheng Feng
Shicheng Feng
SWSheng Wang
Sheng Wang
This study aimed to explore the effect of ultrasound-stimulated microbubbles (USMBs) on tumor radiosensitivity in esophageal carcinoma (EC). The human EC cell line KYSE-510 and human umbilical vein endothelial cells (HUVECs) were exposed to radiation alone or in combination with USMBs. CCK-8, colony formation, and EdU assays were used to determine cell viability and proliferation. Cell apoptosis was assessed using flow cytometry. Cell migration and invasion were examined by wound healing and transwell assays. Western blotting showed that the protein levels were associated with apoptosis, epithelial–mesenchymal transition (EMT), and angiogenesis. An endothelial tube-forming assay was used to detect the angiogenic activity of HUVECs. Xenograft experiments were used to examine the effect of USMBs on EC radiosensitivity in vivo. The expression of Ki-67 in tumors was detected using immunohistochemistry. USMBs enhanced the suppressive effect of radiation on proliferation, migration, invasion, and EMT, and promoted radiation-induced apoptosis in EC cells in vitro. Angiogenesis in EC was suppressed by radiation and further inhibited by the combination of radiation and USMBs. In vivo experiments revealed that USMBs increased the radiosensitivity of ECs to tumor growth. Collectively, USMBs enhanced the effects of radiotherapy in esophageal carcinoma.

16 December 2023 in European Journal of Radiology
Verified
Journal Article
Closed access
JSJinjun Shi
Jinjun Shi
QCQin Chang
Qin Chang
MMMing Ma
Ming Ma
PWPingping Wang
Pingping Wang
LJLi Jia
Li Jia

23 February 2026 in PeerJ
Verified
Journal Article
Open access
PDF file
HSHongyuan Shen
Hongyuan Shen
JLJia Li
Jia Li
GWGuoqing Wang
Guoqing Wang
XSXiangyu Su
Xiangyu Su
ZZZhigang Zhang
Zhigang Zhang
JSJinjun Shi
Jinjun Shi
Background: Liver metastasis accounts for most deaths in colorectal cancer patients, but we still lack a clear understanding of how this devastating process unfolds at the molecular level. Identifying these mechanisms could lead to better ways to predict and treat metastatic disease. Methods: We performed proteomic analysis on 38 tissue samples, including benign adenomas, primary colorectal tumors, and liver metastases, to map the molecular changes that drive cancer spread to the liver. Results: We found striking differences in protein expression patterns across tissue types. Primary tumors showed massive protein changes compared to normal tissue (nearly 1,900 alterations), but liver metastases were surprisingly selective in their modifications (just 89 unique changes from primary tumors). This specificity indicates that liver colonization depends on precise molecular adjustments rather than random cellular disruption. The proteins involved in metastasis fell into three main categories: tissue restructuring to support tumor growth, mechanisms to avoid immune detection, and blood clotting factors that help cancer cells establish themselves in the liver. We validated three biomarkers with clinical potential: HDHD3 shows promise for detecting existing metastases, while OLFM4 and ZNF34 can help identify primary tumors at high risk for spreading. Conclusions: Our work reveals that colorectal cancer liver metastasis involves targeted molecular changes rather than widespread cellular chaos. The biomarkers we identified could improve early detection of metastatic risk and guide more personalized treatment decisions for patients.